melatonin and ucm 454

melatonin has been researched along with ucm 454 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balsamini, C; Diamantini, G; Fraschini, F; Lucini, V; Mor, M; Nonno, R; Pannacci, M; Plazzi, PV; Rivara, S; Spadoni, G; Stankov, BM; Tarzia, G; Tontini, A1
Bedini, A; Fraschini, F; Lucini, V; Mor, M; Pannacci, M; Plazzi, PV; Rivara, S; Silva, C; Spadoni, G; Tarzia, G; Vacondio, F; Zuliani, V1
Bedini, A; Lorenzi, S; Mor, M; Plazzi, PV; Rivara, S; Spadoni, G; Tarzia, G1
Attia, MI; Julius, J; Sethi, S; Witt-Enderby, PA; Zlotos, DP1
Cecon, E; Jockers, R; Rivara, S; Witt-Enderby, PA; Zlotos, DP1

Other Studies

5 other study(ies) available for melatonin and ucm 454

ArticleYear
2-N-acylaminoalkylindoles: design and quantitative structure-activity relationship studies leading to MT2-selective melatonin antagonists.
    Journal of medicinal chemistry, 2001, Aug-30, Volume: 44, Issue:18

    Topics: 3T3 Cells; Animals; Humans; Indoles; Mice; Models, Molecular; Quantitative Structure-Activity Relationship; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Receptors, Melatonin

2001
Three-dimensional quantitative structure-activity relationship studies on selected MT1 and MT2 melatonin receptor ligands: requirements for subtype selectivity and intrinsic activity modulation.
    Journal of medicinal chemistry, 2003, Apr-10, Volume: 46, Issue:8

    Topics: Ligands; Melatonin; Models, Molecular; Models, Statistical; Pyrroles; Quantitative Structure-Activity Relationship; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Receptors, Melatonin

2003
Analysis of structure-activity relationships for MT2 selective antagonists by melatonin MT1 and MT2 receptor models.
    Journal of medicinal chemistry, 2005, Jun-16, Volume: 48, Issue:12

    Topics: Amino Acid Sequence; Animals; Binding, Competitive; Cattle; Humans; Indoles; Mice; Models, Molecular; Molecular Sequence Data; NIH 3T3 Cells; Quantitative Structure-Activity Relationship; Radioligand Assay; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Sequence Homology, Amino Acid

2005
2-[(2,3-dihydro-1H-indol-1-yl)methyl]melatonin analogues: a novel class of MT2-selective melatonin receptor antagonists.
    Journal of medicinal chemistry, 2009, Feb-12, Volume: 52, Issue:3

    Topics: Animals; CHO Cells; Cricetinae; Cricetulus; Indoles; Melatonin; Receptors, Melatonin

2009
MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.
    Journal of medicinal chemistry, 2014, Apr-24, Volume: 57, Issue:8

    Topics: Animals; Binding Sites; Depressive Disorder; Humans; Ligands; Melatonin; Models, Molecular; Protein Multimerization; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Sleep Initiation and Maintenance Disorders; Structure-Activity Relationship

2014